Blocking Blue Light in Pregnancy, Effects on Melatonin Profile and Sleep
Nightly Light Exposure in Pregnancy: Blue-blocking Glasses as an Intervention to Ease Sleep Disturbances and to Improve Mood
1 other identifier
interventional
60
1 country
1
Brief Summary
Sleep disturbances are common in pregnancy, and the incidence increases during the third trimester. Light and specially the blue wavelengths of light, is affecting sleep and the circadian rhythm. The main aim of this randomized controlled study is to investigate the effect of Blue-blocking glasses (BB-glasses) used in the evening and night on sleep and mood in pregnant women in the third trimester. The outcome measures assess sleep variables, alertness, melatonin level, sleepiness (subjectively), mood and symptoms of anxiety and depression. In addition we want to measure the pregnancy related sleep problems, alcohol intake, physical activity and perceives stress in the study population, and the association with daily/nightly light exposure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 24, 2017
CompletedFirst Posted
Study publicly available on registry
April 14, 2017
CompletedStudy Start
First participant enrolled
June 6, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 9, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
ExpectedDecember 18, 2024
December 1, 2024
1.8 years
March 24, 2017
December 16, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Sleep diary
Daily subjective estimates of sleep variables, and will be assessed every morning.
3 weeks in the third trimester of pregnancy, mainly gestational week 28-31
Change in motor activity measured by using Actigraphy.
Objective measure by Actiwatch Spectrum from Philips Respironics. The participants will use the Actiwatch for the whole study period of three weeks.
3 weeks in the third trimester of pregnancy, mainly gestational week 28-31
Melatonin level
Measured by saliva samples.
3 weeks in the third trimester of pregnancy, mainly gestational week 28-31
Secondary Outcomes (10)
Bergen Insomnia Scale (BIS)
3 weeks in the third trimester of pregnancy, mainly gestational week 28-31
Karolinska Sleepiness Scale (KSS)
3 weeks in the third trimester of pregnancy, mainly gestational week 28-31
Evening activation
3 weeks in the third trimester of pregnancy, mainly gestational week 28-31
Sleepiness (subjectively)
3 weeks in the third trimester of pregnancy, mainly gestational week 28-31
Mood
3 weeks in the third trimester of pregnancy, mainly gestational week 28-31
- +5 more secondary outcomes
Study Arms (2)
Blue-blocking glasses
ACTIVE COMPARATORN=30 The Blue-blocking glasses (orange-tinted), which remove more than 99% of the blue wavelengths (wavelengths within the visible spectrum shorter than 530 nm). Luminous transmittance: 50%.
Light grey control glasses
ACTIVE COMPARATORN=30 Partially blue blocking light grey glasses, blocking only about 50% of blue wavelengths (wavelengths within the visible spectra shorter than 530 nm). Luminous transmittance: 55%.
Interventions
Wear the BB-glasses from three hours before bedtime, and if needed to turn on the light, also during the night.
Wear the light grey glasses from three hours before bedtime, and if needed to turn on the light, also during the night.
Eligibility Criteria
You may qualify if:
- nulliparous women
- expecting one child
- being in the third trimester of a normal pregnancy
- able to wear an actigraph during daytime and nighttime
- able to fill out a questionnaire in Norwegian
You may not qualify if:
- somatic or psychiatric disorders
- fever and other health conditions affecting sleep
- working at night during the study protocol
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Randi Liset
Bergen, 5232, Norway
Related Publications (27)
Abbott SM, Attarian H, Zee PC. Sleep disorders in perinatal women. Best Pract Res Clin Obstet Gynaecol. 2014 Jan;28(1):159-68. doi: 10.1016/j.bpobgyn.2013.09.003. Epub 2013 Oct 7.
PMID: 24144530BACKGROUNDAkerstedt T, Gillberg M. Subjective and objective sleepiness in the active individual. Int J Neurosci. 1990 May;52(1-2):29-37. doi: 10.3109/00207459008994241.
PMID: 2265922BACKGROUNDAMERICAN ACADEMY OF SLEEP MEDICINE 2014. International classification of sleep disorders Darien, IL: American Academy of Sleep Medicine, 3.
BACKGROUNDBeck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988 Dec;56(6):893-7. doi: 10.1037//0022-006x.56.6.893. No abstract available.
PMID: 3204199BACKGROUNDBECK, A. T., STEER, R. A. & BROWN, G.A. 1996. Manual for the Beck Depression Inventory-II. San Antonio, TX:Psychological Corporation.
BACKGROUNDBennett S, Alpert M, Kubulins V, Hansler RL. Use of modified spectacles and light bulbs to block blue light at night may prevent postpartum depression. Med Hypotheses. 2009 Aug;73(2):251-3. doi: 10.1016/j.mehy.2009.01.049. Epub 2009 Mar 28.
PMID: 19329259BACKGROUNDBerson DM. Phototransduction in ganglion-cell photoreceptors. Pflugers Arch. 2007 Aug;454(5):849-55. doi: 10.1007/s00424-007-0242-2. Epub 2007 Mar 10.
PMID: 17351786BACKGROUNDBrainard GC, Hanifin JP, Greeson JM, Byrne B, Glickman G, Gerner E, Rollag MD. Action spectrum for melatonin regulation in humans: evidence for a novel circadian photoreceptor. J Neurosci. 2001 Aug 15;21(16):6405-12. doi: 10.1523/JNEUROSCI.21-16-06405.2001.
PMID: 11487664BACKGROUNDBurkhart K, Phelps JR. Amber lenses to block blue light and improve sleep: a randomized trial. Chronobiol Int. 2009 Dec;26(8):1602-12. doi: 10.3109/07420520903523719.
PMID: 20030543BACKGROUNDCarney CE, Buysse DJ, Ancoli-Israel S, Edinger JD, Krystal AD, Lichstein KL, Morin CM. The consensus sleep diary: standardizing prospective sleep self-monitoring. Sleep. 2012 Feb 1;35(2):287-302. doi: 10.5665/sleep.1642.
PMID: 22294820BACKGROUNDCohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983 Dec;24(4):385-96. No abstract available.
PMID: 6668417BACKGROUNDDorheim SK, Bjorvatn B, Eberhard-Gran M. Insomnia and depressive symptoms in late pregnancy: a population-based study. Behav Sleep Med. 2012;10(3):152-66. doi: 10.1080/15402002.2012.660588.
PMID: 22742434BACKGROUNDFacco FL, Kramer J, Ho KH, Zee PC, Grobman WA. Sleep disturbances in pregnancy. Obstet Gynecol. 2010 Jan;115(1):77-83. doi: 10.1097/AOG.0b013e3181c4f8ec.
PMID: 20027038BACKGROUNDGronli J, Byrkjedal IK, Bjorvatn B, Nodtvedt O, Hamre B, Pallesen S. Reading from an iPad or from a book in bed: the impact on human sleep. A randomized controlled crossover trial. Sleep Med. 2016 May;21:86-92. doi: 10.1016/j.sleep.2016.02.006. Epub 2016 Mar 2.
PMID: 27448477BACKGROUNDHauge ER, Berle JO, Oedegaard KJ, Holsten F, Fasmer OB. Nonlinear analysis of motor activity shows differences between schizophrenia and depression: a study using Fourier analysis and sample entropy. PLoS One. 2011 Jan 28;6(1):e16291. doi: 10.1371/journal.pone.0016291.
PMID: 21297977BACKGROUNDHenriksen TE, Skrede S, Fasmer OB, Hamre B, Gronli J, Lund A. Blocking blue light during mania - markedly increased regularity of sleep and rapid improvement of symptoms: a case report. Bipolar Disord. 2014 Dec;16(8):894-8. doi: 10.1111/bdi.12265. Epub 2014 Sep 27.
PMID: 25264124BACKGROUNDJohns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991 Dec;14(6):540-5. doi: 10.1093/sleep/14.6.540.
PMID: 1798888BACKGROUNDMeyer TJ, Miller ML, Metzger RL, Borkovec TD. Development and validation of the Penn State Worry Questionnaire. Behav Res Ther. 1990;28(6):487-95. doi: 10.1016/0005-7967(90)90135-6.
PMID: 2076086BACKGROUNDMilton K, Bull FC, Bauman A. Reliability and validity testing of a single-item physical activity measure. Br J Sports Med. 2011 Mar;45(3):203-8. doi: 10.1136/bjsm.2009.068395. Epub 2010 May 19.
PMID: 20484314BACKGROUNDNicassio PM, Mendlowitz DR, Fussell JJ, Petras L. The phenomenology of the pre-sleep state: the development of the pre-sleep arousal scale. Behav Res Ther. 1985;23(3):263-71. doi: 10.1016/0005-7967(85)90004-x. No abstract available.
PMID: 4004706BACKGROUNDNodine PM, Matthews EE. Common sleep disorders: management strategies and pregnancy outcomes. J Midwifery Womens Health. 2013 Jul-Aug;58(4):368-77. doi: 10.1111/jmwh.12004. Epub 2013 Jul 15.
PMID: 23855316BACKGROUNDPallesen S, Bjorvatn B, Nordhus IH, Sivertsen B, Hjornevik M, Morin CM. A new scale for measuring insomnia: the Bergen Insomnia Scale. Percept Mot Skills. 2008 Dec;107(3):691-706. doi: 10.2466/pms.107.3.691-706.
PMID: 19235401BACKGROUNDRØYSAMB, E., VITTERSØ, J. & TAMBS, K. 2014. The Relationship Satisfaction scale-psychometric properties. Norsk Epidemiologi, 24, 187-94.
BACKGROUNDSivertsen B, Omvik S, Havik OE, Pallesen S, Bjorvatn B, Nielsen GH, Straume S, Nordhus IH. A comparison of actigraphy and polysomnography in older adults treated for chronic primary insomnia. Sleep. 2006 Oct;29(10):1353-8. doi: 10.1093/sleep/29.10.1353.
PMID: 17068990BACKGROUNDWatson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol. 1988 Jun;54(6):1063-70. doi: 10.1037//0022-3514.54.6.1063.
PMID: 3397865BACKGROUNDWilson DL, Barnes M, Ellett L, Permezel M, Jackson M, Crowe SF. Decreased sleep efficiency, increased wake after sleep onset and increased cortical arousals in late pregnancy. Aust N Z J Obstet Gynaecol. 2011 Feb;51(1):38-46. doi: 10.1111/j.1479-828X.2010.01252.x. Epub 2010 Dec 7.
PMID: 21299507BACKGROUNDLiset R, Gronli J, Henriksen RE, Henriksen TEG, Nilsen RM, Pallesen S. A randomized controlled trial on the effects of blue-blocking glasses compared to partial blue-blockers on sleep outcomes in the third trimester of pregnancy. PLoS One. 2022 Jan 28;17(1):e0262799. doi: 10.1371/journal.pone.0262799. eCollection 2022.
PMID: 35089982DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Randi Liset, PhD
University of Bergen
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- Consenting participants will be randomized (by www.randomizer.org) to either intervention/control condition. The intervention- and control glasses will be covered in the same looking wrapping, done by a third person, which will blind the investigator as well.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 24, 2017
First Posted
April 14, 2017
Study Start
June 6, 2017
Primary Completion
April 9, 2019
Study Completion (Estimated)
July 1, 2026
Last Updated
December 18, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share